Poster Abstract Session:
148. Respiratory Infections: Miscellaneous
Friday, October 5, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Epidemiology and Infection Control, Global ID, Pediatric ID

Case Report: Andes Virus Hantavirus Pulmonary Syndrome in a Traveler Returning to the united States
David Bergamo, PA-C; Alfred Bacon, MD; David Cohen, MD; Paula Eggers, RN; Aaron Kofman, MD; Mary Choi, MD, MPH; John Klena, PhD
  • FINAL ANDV POSTER.pdf (1.3 MB)
  • Etiology of Pulmonary Granulomas: How Common is Unsuspected Infection?
    Barbara Alvarez, MD; Edward K. Chapnick, MD, FIDSA, FSHEA; Monica Ghitan, MD, FIDSA; Yu Shia Lin, MD
    Etiology and outcome of fever and respiratory distress in adult patients presenting to medical emergency in a tertiary care hospital in north India
    Vikas Suri, MBBS MD(MED); Harshit R Rao, MBBS MD(MED); Ashish Bhalla, MBBS MD(MED); Inderpaul Singh, MBS MD DM(PUL MED); Manisha Biswal, MBBS MD(MICROBIOLOGY); Mini P Singh, MBBS MD(MICROBIOLOGY); Kapil Goyal, MBBS MD(MICROBIOLOGY); Kamran Zaman, MBBS MD(MICROBIOLOGY)
    Objective Surveillance Definitions for Hospital-Acquired Pneumonia in Non-Ventilated Patients
    Wenjing Ji, MS; Cara Smith, MPH; Zilu Zhang, MS; Aileen Ochoa, MPH; Jessica Young, PhD; Chanu Rhee, MD, MPH; Michael Klompas, MD, MPH
    Evaluating the Impact of Procalcitonin on Antibiotic Utilization in Chronic Obstructive Pulmonary Disease Exacerbations
    Kevin Lin, PharmD; Casey Dempsey, PharmD; Shivani Patel, PharmD, BCPS; John Butler, MD; Edward Septimus, MD, FIDSA, FSHEA
  • ID Week Poster draft 4.pdf (503.7 kB)
  • Impact of a Guidance Document, Order Set Changes and Physician Education on Antibiotic Prescribing in Acute Exacerbation of COPD
    Jayme Anderson, PharmD, BCPS; Spencer Evans, PharmD candidate; Scott Bergman, PharmD, FIDSA, FCCP, BCPS; Trevor Van Schooneveld, MD, FACP
    Clinical Outcomes of Escherichia coli Infections in Cystic Fibrosis (CF) Patients
    Brett Edwards, M.D.; Jasper Greysson-Wong, B.Sc.; Ranjani Somayaji, M.D.; Barbara Waddell, BSc.; Doug Storey, PHD; Michael Surette, MD; Harvey Rabin, MD; Michael Parkins, MD
    Pleural Empyema Caused by Stenotrophomonas maltophilia in A National Cohort of Hospitalized Veterans
    Ramy Masroujeh, MD; Elie Saade, MD, MPH; Brigid Wilson, PhD; Federico Perez, MD, MS; Robert A. Bonomo, MD
    Impact of Combination Versus Monotherapy on Clinical Outcomes Associated with Stenotrophomonas maltophilia Pneumonia
    Megan Shah, PharmD; Kelci Coe, MPH; Zeinab ElBoghdadly, MBBCh; Lynn Wardlow, PharmD, MBA, BCPS-AQ ID; Jennifer Dela-Pena, PharmD; Kurt Stevenson, MD, MPH, FSHEA; Erica Reed, PharmD, BCPS-AQ ID
    Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Contemporary (2015-2017) Gram-Negative Isolates from Patients with Pneumonia in US Medical Centers
    S J Ryan Arends, Ph.D.; Dee Shortridge, Ph.D.; Leonard R. Duncan, Ph.D.; Jennifer M. Streit, BS; Robert K. Flamm, PhD
    Variability of Pneumocystis jirovecii Prophylaxis Use Among Pediatric Solid Organ Transplant Providers
    Grant Paulsen, MD; Marian Michaels, MD, MPH; Lara Danziger-Isakov, MD, MPH; Anne Dipchand, MD; Michael Green, MD, MPH, FIDSA; Mignon McCulloch, MD
  • PJP IDWeek_Final_9.27.18.pdf (432.5 kB)
  • Invasive Pulmonary Aspergillosis in Patients with Solid Tumors: Risk Factors and Predictors of Clinical Outcomes.
    Dima Dandachi, M.D.; Rita Wilson Dib, MD; Ana Fern√°ndez-Cruz, M.D., Ph.D.; Ying Jiang, MS; Ray Y. Hachem, MD; Anne-Marie Chaftari, MD; Issam Raad, MD
  • ID week 2018_Poster.IPA.pdf (1014.4 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.